CD80 and myeloid sarcoma: Study of the expression of CD80, a costimulatory signal necessary for T cell activation and survival, on PBMCs in response to the MBP peptide revealed that GK16 and QR24 increased the expression of CD80 on cells from both MS patients and HDs (Figure 1C).